Apricus Biosciences (Nasdaq: APRI) announced the launch in Germany of Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction ("ED") ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE